InMode (INMD)
(Delayed Data from NSDQ)
$17.41 USD
+0.07 (0.40%)
Updated Apr 19, 2024 04:00 PM ET
After-Market: $17.42 +0.01 (0.06%) 4:32 PM ET
4-Sell of 5 4
B Value D Growth D Momentum C VGM
Price, Consensus and EPS Surprise
INMD 17.41 +0.07(0.40%)
Will INMD be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for INMD based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for INMD
InMode (INMD) Ascends But Remains Behind Market: Some Facts to Note
Is InMode (INMD) a Buy as Wall Street Analysts Look Optimistic?
INMD: What are Zacks experts saying now?
Zacks Private Portfolio Services
InMode Ltd. (INMD) is Attracting Investor Attention: Here is What You Should Know
Why InMode (INMD) Outpaced the Stock Market Today
InMode (INMD) Stock Falls Amid Market Uptick: What Investors Need to Know
Other News for INMD
Commit To Purchase InMode At $10, Earn 11% Using Options
InMode Responds To BTL Petition for Inter Partes Review Of Patent InMode Is Asserting Against BTL
InMode responds to petition to USPTO filed by BTL Industries
Analysts Are Bullish on Top Healthcare Stocks: InMode (INMD), Resmed (RMD)
3 Best Stocks to Buy Now, 4/12/2024, According to Top Analysts